VNVC and Sanofi Group (France) cooperate in transferring vaccine production technology

According to the cooperation agreement, VNVC and Sanofi will gradually implement technology transfer to produce some important types of Sanofi vaccines used in large quantities in Vietnam. In addition, Sanofi will also accompany VNVC in training human resources and quality management in vaccine research and production.

The two sides exchanged documents on cooperation agreement on vaccine production technology transfer under the witness ofPresident Luong Cuong and President of the French Republic Emmanuel Macron.

Vietnam Vaccine Company (VNVC) and Sanofi Pharmaceutical Group (France) have just signed a cooperation agreement on transferring Sanofi's vaccine production technology at the VNVC Vaccine and Biological Factory in Vietnam. The event is part of the State visit of the French President to Vietnam, at the invitation of President Luong Cuong.

Mr. Ngo Chi Dung, General Director and Chairman of the Board of Directors of VNVC Vaccine Company, said that in the context that the Party and the State are creating the most favorable conditions for the development of the private economy , especially in the field of international cooperation in science and technology, the cooperation in technology transfer with Sanofi, France - the world's leading vaccine manufacturer is an important cooperation, helping VNVC in particular, and the Vietnamese vaccine manufacturing industry in general, to quickly improve production capacity to produce "made in Vietnam" vaccines of high quality comparable to the world.

VNVC staff are vaccinating children

Technology transfer allows Vietnam to quickly access leading modern technologies, optimize research and development activities, promptly serve domestic needs and firmly ensure national health security.

“Proactive domestic production will help ensure adequate supply of high-quality vaccines and reduce vaccine costs for people. This will be of great significance in the vaccine coverage strategy, protecting the health of all people, thereby reducing the burden of disease, reducing medical examination and treatment costs, and improving the quality of life,” Mr. Ngo Chi Dung expected.

At the same time, Mr. Ngo Chi Dung said that in the strategic vision of contributing to the goal of national vaccine self-sufficiency, VNVC will build a modern VNVC Vaccine and Biological Products Factory, with a scale of up to ^26,000m2 in Long An province. With an initial investment of VND 2,000 billion, the VNVC vaccine factory is designed to meet the highest standards of the most modern Good Manufacturing Practices (GMP) of the World Health Organization (WHO), the European Union (EU), and the US Food and Drug Administration (FDA).

THANH SON

Source: https://www.sggp.org.vn/vnvc-va-tap-doan-sanofi-phap-hop-tac-chuyen-giao-cong-nghe-san-xuat-vaccine-post796979.html